AIM Exam Arena • 3rd Year MBBS

Question:

A 36-year-old man with allergic rhinitis is prescribed chlorpheniramine. His symptoms improve, but he asks why the drug may affect his ability to work safely with machinery. Which classification of this drug best predicts this problem?

Options:

Correct Answer: First-generation H1 antagonist

Explanation: Chlorpheniramine belongs to the first generation of H1 antagonists; drugs in this group can enter the CNS and impair alertness through central H1 blockade.

Question:

A patient develops an itchy erythematous reaction after allergen exposure. Histamine released locally acts on small blood vessels and sensory nerve endings. Which change would be expected after administration of an effective H1 antagonist?

Options:

Correct Answer: Reduced edema with less pruritus

Explanation: H1 blockade reduces histamine-induced vascular leakage and sensory nerve stimulation, thereby reducing tissue swelling and itching.

Question:

A 45-year-old office worker with recurrent urticaria is changed from diphenhydramine to fexofenadine. His skin symptoms remain controlled while his daytime performance improves. Fexofenadine belongs to which pharmacological group?

Options:

Correct Answer: Second-generation H1 antagonists

Explanation: Fexofenadine is a second-generation H1 antagonist. This group provides peripheral antiallergic activity with comparatively little CNS effect.

Question:

A 54-year-old man taking an older antihistamine develops constipation and difficulty passing urine. The physician explains that these effects are unrelated to blockade of the receptor responsible for his allergic symptoms. Which pharmacological action is responsible?

Options:

Correct Answer: Muscarinic receptor blockade

Explanation: Older H1 antihistamines may also block muscarinic receptors, producing constipation, urinary retention, dry mouth and impaired accommodation.

Question:

A 23-year-old woman takes an H1 antagonist for allergy and later takes another medication that also causes marked CNS depression. She becomes considerably more drowsy than expected. Which interaction best accounts for this observation?

Options:

Correct Answer: Additive central depressant effects

Explanation: Sedating first-generation H1 antagonists can enhance the effects of other CNS depressants, producing greater impairment than either drug alone.

Question:

A pharmacologist studies a mediator that influences gastrointestinal signaling, vascular tone, platelet-associated responses and CNS function. The effects differ substantially between tissues despite the same mediator being present. Which feature best accounts for this variation?

Options:

Correct Answer: Presence of different 5-HT receptor subtypes

Explanation: Serotonin acts through several receptor subtypes whose distribution and signaling differ between organs, producing tissue-specific physiological responses.

Question:

During a pharmacology discussion, students compare buspirone with sumatriptan. Both influence serotonergic transmission but act at different receptor subtypes. Which description correctly identifies buspirone?

Options:

Correct Answer: Partial 5-HT1A receptor agonist

Explanation: Buspirone has partial agonist activity at 5-HT1A receptors, illustrating that serotonin agonists can be distinguished by receptor subtype.

Question:

A patient receiving cytotoxic therapy is given an antiemetic before treatment. The drug does not prevent serotonin release from the intestinal mucosa but prevents the released mediator from initiating an important afferent signal. Which drug best fits this mechanism?

Options:

Correct Answer: Ondansetron

Explanation: Ondansetron blocks 5-HT3 receptors involved in transmitting serotonin-mediated emetic signals without preventing serotonin release itself.

Question:

A drug under study produces rapid neuronal excitation after serotonin binds to its target. Unlike the other serotonin receptors being studied, this receptor directly controls an ion channel. Which receptor is responsible?

Options:

Correct Answer: 5-HT3 receptor

Explanation: The 5-HT3 receptor is a ligand-gated ion channel; the major remaining serotonin receptor families signal through G proteins.

Question:

A patient with recurrent migraine receives a drug that selectively activates a serotonin receptor subtype rather than blocking serotonergic transmission. Which agent has the required pharmacological action?

Options:

Correct Answer: Sumatriptan

Explanation: Sumatriptan is a serotonin agonist acting mainly at 5-HT1B/1D receptors and is clinically useful in migraine.

Question:

Two serotonin antagonists are compared during a pharmacology viva. One selectively interrupts the emetic pathway, whereas the other has 5-HT2-blocking as well as antihistaminic activity. Which drug represents the latter?

Options:

Correct Answer: Cyproheptadine

Explanation: Cyproheptadine has important 5-HT2 antagonist activity together with H1 antihistaminic action, distinguishing it from selective 5-HT3 blockade by ondansetron.

Question:

Soon after chemotherapy, serotonin released from gastrointestinal enterochromaffin cells initiates a sequence that ends in vomiting. Which intervention point explains the effectiveness of a selective 5-HT3 antagonist?

Options:

Correct Answer: Blockade of serotonin action on vagal afferents

Explanation: Gastrointestinal serotonin activates 5-HT3 receptors on vagal afferent endings; receptor blockade interrupts transmission toward central vomiting pathways.

Question:

A toxic substance has entered the gastrointestinal tract. An agent is administered that remains available to bind the toxic material physically and thereby decreases its absorption rather than acting at a receptor. How should this antidotal action be classified?

Options:

Correct Answer: Physical antidotal action

Explanation: A physical antidote reduces toxicity through adsorption or another physical interaction that limits absorption rather than by receptor blockade.

Question:

A patient is poisoned by a substance that impairs an essential biochemical process. The selected antidote restores the function that was inhibited rather than merely treating the patient’s symptoms. Which mechanism best describes this action?

Options:

Correct Answer: Biochemical or enzyme-function restoration

Explanation: Some antidotes act by restoring an enzyme or biochemical function disrupted by the toxin, directly opposing an important mechanism of toxicity.

Question:

A patient has systemic toxicity from a substance that can be tightly bound by a therapeutic agent, forming a complex with reduced ability to interact with tissues. Which antidotal principle is being applied?

Options:

Correct Answer: Chelation or chemical binding

Explanation: Chelating or chemically binding antidotes reduce the ability of a toxic substance to interact with tissues and may facilitate its removal.

Question:

An unconscious patient with suspected poisoning arrives in the emergency department. After the airway is secured and breathing and circulation are stabilized, relatives provide a container found beside the patient. Which next approach is most useful for directing further management?

Options:

Correct Answer: Focused exposure history with clinical examination

Explanation: Once immediate life threats are controlled, the substance, route, timing and circumstances of exposure together with examination findings guide subsequent toxicological management.

Question:

A farm worker is brought from an area where a toxic substance was spilled onto his clothes. He is conscious and cardiorespiratory status is stable, but his clothing remains contaminated. Which management principle should now receive priority?

Options:

Correct Answer: Stop continuing external exposure safely

Explanation: After stabilization, ongoing exposure should be terminated safely; contaminated clothing or external contamination may require appropriate removal.

Question:

A patient with an unidentified poisoning is stabilized and monitored. No appropriate specific antidote is available, but respiratory and circulatory disturbances are treated as they develop. Which principle best explains why this approach can still be effective?

Options:

Correct Answer: Supportive care maintains vital function during toxin clearance

Explanation: Supportive care is fundamental in poisoning because maintaining vital physiological functions allows time for the toxin to be metabolized or eliminated.

Question:

A patient has already received initial stabilization and appropriate supportive treatment for poisoning. The toxic substance is subsequently identified, and a suitable antidote exists. How should the antidote be incorporated into management?

Options:

Correct Answer: Add it to ongoing stabilization and supportive care

Explanation: A specific antidote complements resuscitation and supportive treatment; its availability does not remove the need to maintain vital functions and monitor the patient.

Question:

A patient with poisoning is clinically improving after several hours of supportive treatment. The team considers ending observation because the initial symptoms have resolved. Which feature of poisoning management provides the strongest reason to continue monitoring?

Options:

Correct Answer: Toxic effects may evolve or recur after initial improvement

Explanation: Poisoning may have delayed or recurrent manifestations, so apparent early recovery does not remove the need for continued observation and reassessment.